Geographic variation in 5-year mortality following HIV diagnosis: implications for clinical interventions
- PMID: 36942651
- PMCID: PMC10511661
- DOI: 10.1080/09540121.2023.2189224
Geographic variation in 5-year mortality following HIV diagnosis: implications for clinical interventions
Abstract
Characterizing spatial distribution of HIV outcomes is vital for targeting interventions to areas most at risk. We performed spatial analysis to identify geographic clusters and factors associated with mortality in KwaZulu-Natal, South Africa. We utilized Sizanani trial (NCT01188941) data, which enrolled participants August 2010-January 2013 and obtained vital status at 5.8 (IQR 5.0-6.4) years of follow-up. We mapped geocoded addresses to 2011 Census-defined small area layer (SAL) centroids, used Kulldorff's spatial scan statistic to identify mortality clusters, and compared socio-demographic factors for SALs within and outside mortality clusters. We assigned 1,143 participants living with HIV (260 [23%] of whom died during follow-up) to 677 SALs. One lower mortality cluster (n = 90, RR = 0.23, p = 0.022) was identified near a hospital outside Durban. SALs in the cluster were younger (24y vs 25y, p < 0.001); had fewer bedrooms/household (3 vs 4, p < 0.001); had more females (52% vs 51%, p = 0.013) and residents with no schooling past age 20 (4% vs 3%, p < 0.001) or no education at all (4% vs 3%, p < 0.001); had fewer residents with income >3,200 ZAR/month (5% vs 9%, p < 0.001); and had reduced access to piped water (p < 0.001), refuse disposal (p < 0.001), and toilets (p < 0.001). Targeted interventions may improve outcomes in areas with similar characteristics.
Keywords: HIV/AIDS; South Africa; geographical information systems; mortality.
Conflict of interest statement
Declaration of interest statement
The authors declare that they have no competing interests.
Figures
References
-
- Bassett IV, Coleman SM, Giddy J, Bogart LM, Chaisson CE, Ross D, Flash MJE, Govender T, Walensky RP, Freedberg KA, & Losina E (2017). Barriers to care and 1-year mortality among newly diagnosed HIV-infected people in Durban, South Africa. Journal of Acquired Immune Deficiency Syndromes (1999), 74(4), 432–438. 10.1097/QAI.0000000000001277 - DOI - PMC - PubMed
-
- Bassett IV, Coleman SM, Giddy J, Bogart LM, Chaisson CE, Ross D, Jacobsen MM, Robine M, Govender T, Freedberg KA, Katz JN, Walensky RP, & Losina E (2016). Sizanani: A randomized trial of health system navigators to improve linkage to HIV and TB care in South Africa. Journal of Acquired Immune Deficiency Syndromes (1999), 73(2), 154–160. 10.1097/QAI.0000000000001025 - DOI - PMC - PubMed
-
- Bassett IV, Giddy J, Chaisson CE, Ross D, Bogart LM, Coleman SM, Govender T, Robine M, Erlwanger A, Freedberg KA, Katz JN, Walensky RP, & Losina E (2013). A randomized trial to optimize HIV/TB care in South Africa: Design of the Sizanani trial. BMC Infectious Diseases, 13, 390. 10.1186/1471-2334-13-390 - DOI - PMC - PubMed
-
- Bassett IV, Regan S, Mbonambi H, Blossom J, Bogan S, Bearnot B, Robine M, Walensky RP, Mhlongo B, Freedberg KA, Thulare H, & Losina E (2015). Finding HIV in hard to reach populations: Mobile HIV testing and geospatial mapping in Umlazi township, Durban, South Africa. AIDS and Behavior, 19(10), 1888–1895. 10.1007/s10461-015-1012-3 - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous